85 related articles for article (PubMed ID: 8200844)
1. Differentiation of a Ewing's sarcoma cell line towards neural and mesenchymal cell lineages.
Kodama K; Doi O; Higashiyama M; Yokouchi H; Tateishi R; Mori Y
Jpn J Cancer Res; 1994 Apr; 85(4):335-8. PubMed ID: 8200844
[TBL] [Abstract][Full Text] [Related]
2. Dynamic model of differentiation in Ewing's sarcoma cells. Comparative analysis of morphologic, immunocytochemical, and oncogene expression parameters.
Noguera R; Triche TJ; Navarro S; Tsokos M; Llombart-Bosch A
Lab Invest; 1992 Feb; 66(2):143-51. PubMed ID: 1310513
[TBL] [Abstract][Full Text] [Related]
3. Chondrocytic differentiation of peripheral neuroectodermal tumor cell line in nude mouse xenograft.
Goji J; Sano K; Nakamura H; Ito H
Cancer Res; 1992 Aug; 52(15):4214-20. PubMed ID: 1379122
[TBL] [Abstract][Full Text] [Related]
4. Patterns of differentiation in extraosseous Ewing's sarcoma cells. An in vitro study.
Noguera R; Navarro S; Peydró-Olaya A; Llombart-Bosch A
Cancer; 1994 Feb; 73(3):616-24. PubMed ID: 7507797
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of a new Ewing's sarcoma cell line.
Kodama K; Doi O; Higashiyama M; Mori Y; Horai T; Tateishi R; Aoki Y; Misawa S
Cancer Genet Cytogenet; 1991 Nov; 57(1):19-30. PubMed ID: 1756482
[TBL] [Abstract][Full Text] [Related]
6. Experimental evidence for a neural origin of Ewing's sarcoma of bone.
Cavazzana AO; Miser JS; Jefferson J; Triche TJ
Am J Pathol; 1987 Jun; 127(3):507-18. PubMed ID: 3035930
[TBL] [Abstract][Full Text] [Related]
7. Neuronal differentiation of Ewing's sarcoma induced by cholera toxin B and bromodeoxyuridine--establishment of Ewing's sarcoma cell line and histochemical study.
Ohta S; Suzuki A; Shimada M; Kosuga M; Taga T; Sugiura Y; Iwai M; Miyahira Y; Okabe H; Suzuki S
Acta Paediatr Jpn; 1991 Aug; 33(4):428-33. PubMed ID: 1792900
[TBL] [Abstract][Full Text] [Related]
8. Evidence for heterogeneous groups of neuronal differentiation of Ewing's sarcoma.
Hara S; Adachi Y; Kaneko Y; Fujimoto J; Hata J
Br J Cancer; 1991 Dec; 64(6):1025-30. PubMed ID: 1764362
[TBL] [Abstract][Full Text] [Related]
9. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
[TBL] [Abstract][Full Text] [Related]
10. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
[TBL] [Abstract][Full Text] [Related]
11. Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.
Murakami T; Li S; Han Q; Tan Y; Kiyuna T; Igarashi K; Kawaguchi K; Hwang HK; Miyake K; Singh AS; Nelson SD; Dry SM; Li Y; Hiroshima Y; Lwin TM; DeLong JC; Chishima T; Tanaka K; Bouvet M; Endo I; Eilber FC; Hoffman RM
Oncotarget; 2017 May; 8(22):35630-35638. PubMed ID: 28404944
[TBL] [Abstract][Full Text] [Related]
12. Herceptin down-regulates HER-2/neu and vascular endothelial growth factor expression and enhances taxol-induced cytotoxicity of human Ewing's sarcoma cells in vitro and in vivo.
Guan H; Jia SF; Zhou Z; Stewart J; Kleinerman ES
Clin Cancer Res; 2005 Mar; 11(5):2008-17. PubMed ID: 15756027
[TBL] [Abstract][Full Text] [Related]
13. The histopathology of a human mesenchymal stem cell experimental tumor model: support for an hMSC origin for Ewing's sarcoma?
Burns JS; Abdallah BM; Schrøder HD; Kassem M
Histol Histopathol; 2008 Oct; 23(10):1229-40. PubMed ID: 18712675
[TBL] [Abstract][Full Text] [Related]
14. Ewing's sarcoma cells with CD57-associated increase of tumorigenicity and with neural crest-like differentiation capacity.
Wahl J; Bogatyreva L; Boukamp P; Rojewski M; van Valen F; Fiedler J; Hipp N; Debatin KM; Beltinger C
Int J Cancer; 2010 Sep; 127(6):1295-307. PubMed ID: 20104521
[TBL] [Abstract][Full Text] [Related]
15. What's new in Ewing's tumor?
Loizaga JM
Pathol Res Pract; 1993 Jun; 189(5):616-20. PubMed ID: 8378185
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide concentration determines the fate of Ewing's sarcoma family tumors and neuroblastoma cells in vitro.
Jung HS; Kim HS; Lee MJ; Shin HY; Ahn HS; Ryu KH; Seoh JY; Kim CJ; Jang JJ
FEBS Lett; 2006 Sep; 580(20):4969-75. PubMed ID: 16930595
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
Int J Oncol; 2016 Apr; 48(4):1531-40. PubMed ID: 26846737
[TBL] [Abstract][Full Text] [Related]
19. EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells.
Riggi N; Suvà ML; Suvà D; Cironi L; Provero P; Tercier S; Joseph JM; Stehle JC; Baumer K; Kindler V; Stamenkovic I
Cancer Res; 2008 Apr; 68(7):2176-85. PubMed ID: 18381423
[TBL] [Abstract][Full Text] [Related]
20. [Establishment of Characterization of Seki cell line from an Ewing's sarcoma].
Nojima T; Inoue K; Nagashima K; Abe S; Sasaki M; Yamawaki S
Hum Cell; 1989 Jun; 2(2):192-3. PubMed ID: 2486607
[No Abstract] [Full Text] [Related]
[Next] [New Search]
